主页文献库搜索
Comprehensive analysis of BRCA1/2 mutations, "BRCAness" and PARP inhibitors i...

Stylianakis(D),Stylianakis(I),Benjamin(HA)... Crit Rev Oncol Hematol 2025-11-00

The BRCA1 and BRCA2 genes encode critical proteins in the homologous recombination (HR) DNA repair pathway. While their ...

Beyond BRCA deficiency: Clinical and molecular predictors of survival in pati...

Zwimpfer(TA),Fereday(S),Pandey(A),Ariyarat... medRxiv 2025-09-22

...BRCA2-deficient HGSC and loss of NF1 survived twice as long as those without NF1 loss, whereas PIK3CA or RAD21 amplifica...

Targeting RAD52 overcomes PARP inhibitor resistance in preclinical Brca2-defi...

Ota(Y),Gupta(V),Fashemi(BE),Akande(M),Babu... bioRxiv 2025-09-26

...Brca2-deficient mouse ovarian cancer models, ID8-OR and HGS2-OR. HGS2-OR cells had higher RAD52 expression than parental...

A case report on IDH-mutant astrocytoma, CNS WHO grade 4: multi-omic characte...

Tang(X),Wei(W),Huang(Y),Zheng(Y),Xu(Y),Li(... Front Oncol 2025-00-00

...BRCA2, and RPA4, and showed a 70% increase in NAF1 mutant allele frequency. Pathway analysis revealed MSP-RON and NF-κB ...

Potential New Tumors Associated with Hereditary Breast and Ovarian Cancer (HB...

Nakamura(K),Masuda(K),Seki(T),Kitago(M),Ko... Keio J Med 2025-09-25

Hereditary breast and ovarian cancer syndrome (HBOC) is traditionally associated with mutations in the BRCA1 and BRCA2 g...

Current Situation and Future Directions of Risk-reducing Salpingo-oophorectom...

Masuda(K),Kobayashi(Y),Seki(T),Yoshihama(T... Keio J Med 2025-09-25

...BRCA2 PVs, respectively. Risk-reducing salpingo-oophorectomy (RRSO) is a recommended preventive strategy that reduces th...

Exploring Breast Cancer Risk Management in HBOC Patients: Image Surveillance ...

Seki(T),Kobayashi(Y),Masuda(K),Nakamura(K)... Keio J Med 2025-09-25

...BRCA2 mutations typically result in luminal-type disease. Key risk management strategies include surveillance and prophy...

Reclassification of BRCA1 and BRCA2 Variants of Unknown Significance in a Tur...

Özer(L),Aktuna(S),Ünsal(E) Eur J Breast Health 2025-09-25

...BRCA2 variants. A total of 264 BRCA1/BRCA2 variants were detected. Of these, 130 (49.2%) were pathogenic variants (PV), ...

The Discovery of RP-2119: A Potent, Selective, and Orally Bioavailable Polθ A...

Mochirian(P),Papp(R),Mathieu(MC),Ferraro(G... J Med Chem 2025-09-25

...BRCA2 mutations. Here, we describe the discovery and preclinical development of RP-2119, a selective, potent, and bioava...

Integrative Genomic and Clinicopathologic Characterization of Pure Primary Ov...

Yoon(H),Kim(C),Lee(Y),Ahn(J),Jeong(M) Curr Oncol 2025-09-27

...BRCA2 frameshift mutation (c.7177dupA), an ATM nonsense mutation, and Tier II mutations in TP53 and PTEN. The tumor exhi...

上一页 62 63 64 65 66 67 68 69 70 下一页 66 / 共 630

联系地址

山东省济南市章丘区文博路2号

齐鲁师范学院 genelibs生信实验室

山东省济南市高新区舜华路750号

大学科技园北区F座4单元2楼

电话: 0531-88819269

微信公众号

关注微信订阅号,实时查看信息,关注医学生物学动态。


商务邮箱

E-mail: product@genelibs.com